Immunovia AB (IMMVF)
Sector: Medical - Diagnostics & Research
Industry: Medical - Diagnostics & Research
Immunovia AB
OTC:IMMVFHealthcare · Medical - Diagnostics & Research
CLOSED
Mkt Cap-
EV-
Float654.34M
O/S672.67M
VOL1K sh
$ Vol$1
RVOL0.50×
Inst Own-
Net Cash/Sh-
EarningsFeb 11 · in 3mo
Dilution
MCap-Float654.34MO/S672.67M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 9, 2026 | 0.0010 | 0.0010 | 0.0010 | 0.0010 | 2,000 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About
Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases.
Its technology platform, IMMray, focuses on the early diagnosis of cancer, predicts disease progression, and monitors therapeutic responsiveness of cancers.
The company was founded by Karl Arne Krister Borrebaeck on May 24, 2007 and is headquartered in Lund, Sweden.
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
based on 672.67M shares outstanding
SectorHealthcare
IndustryMedical - Diagnostics & Research
ExchangeOTC
Country
SE
IPO Date-
Shares Outstanding672.67M
Authorized Shares
Float654.34M
52-Week Range
Volume
Average Daily Volume2.00K
30d Avg
2.00K
60d Avg
2.00K
90d Avg
3.00K
Earnings
Dividend History
No dividend history available